Venture Capital Investment in Genomic Tool Shops Fell Across the Board in 2003 | GenomeWeb

NEW YORK, Feb. 19 (GenomeWeb News) - Private-equity investments in genomics-related tool and technology companies shrank 25 percent in 2003 compared with 2002, according to a venture capital-tracking newsletter.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.